Drug class
First-generation phenothiazine antipsychotic; sedative and behavioural-control agent
Mechanism of action
A phenothiazine with central dopaminergic and adrenergic antagonistic activity, together with anticholinergic and sedative effects. Its clinical pharmacology is consistent with first-generation phenothiazine antipsychotics.
General use cases
- Adjunctive treatment in selected psychotic disorders, particularly where agitation, hostility or impulsive behaviour is a treatment concern, according to local product authorisation.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
